KrASIA Report: The Development of the Vaccine Industry in China

With the chaos caused by Covid-19, new hope began to emerge with the distribution of vaccines to various countries, including Indonesia. So far, several countries have researched and developed the distributed vaccine, one of which is China with its products such as Sinovac and Sinopharm.

To provide an overview of the state of the vaccine industry in China, KrASIA released a report entitled "The Vaccine Industry". It contains five main topics, as follows:

• Vaccine industry supply and demand.
• The gap between the development of the vaccine industry in China and the rest of the world.
• Challenges in China.
• A promising sub-vertical and emerging vaccine startup in post-pandemic China.
• Macro outlook for trends shaping the future of the global vaccine business.

The results of this research are interesting to observe, because based on the captured trends, the vaccine industry in China will go through a period of rapid development in the near future. There are several supporting factors, including domestic and investment policies.

For the full review, download the report via the following link: The Vaccine Industry in China.

-

Disclosure: KRASIA in collaboration with DS/innovate to distribute this report.